• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在食管胃十二指肠镜检查筛查中的有效性。

Effectiveness of Artificial Intelligence in Screening Esophagogastroduodenoscopy.

作者信息

Adachi Kyoichi, Ebisutani Yuri, Matsubara Yuko, Okimoto Eiko, Ishimura Norihisa, Ishihara Shunji

机构信息

Health Center, Shimane Environment and Health Public Corporation, Matsue, JPN.

Second Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, JPN.

出版信息

Cureus. 2025 Mar 2;17(3):e79935. doi: 10.7759/cureus.79935. eCollection 2025 Mar.

DOI:10.7759/cureus.79935
PMID:40177429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11962169/
Abstract

BACKGROUND

This retrospective study investigated the usefulness of the EW10-EG01 artificial intelligence (AI) application for screening esophagogastroduodenoscopy (EGD).

METHODOLOGY

A total of 7,655 subjects (4,863 men, 2,792 women; mean age 54.9±10.1 years) who underwent EGD during a medical checkup were enrolled in the study. The number of diagnosed upper gastrointestinal tumors was compared between EGD examinations performed with and without the AI system.

RESULTS

EGD examinations with and without the AI system were performed on 3,841 and 3,814 subjects, respectively. Biopsy procedures were more frequently performed, and examination time was longer in EGD with AI applications than in those without. Upper gastrointestinal tumors diagnosed by EGD with and without AI were 39 (1.02%) and 24 (0.63%), respectively ( = 0.062). There was a significant difference in the detection rate of esophageal and gastric tumors between EGD with (30, 0.78%) and without (14, 0.37%) the AI system (= 0.017). When endoscopists were divided into three groups based on their experience with the EW10-EG01 application, higher detection rates of esophageal and gastric tumors were observed in each group when using EGD with AI.

CONCLUSIONS

Usage of the EW10-EG01 AI system may be useful for screening EGD due to the increased esophageal and gastric tumor detection rate.

摘要

背景

本回顾性研究调查了EW10 - EG01人工智能(AI)应用于食管胃十二指肠镜检查(EGD)筛查的有效性。

方法

共有7655名在体检期间接受EGD检查的受试者(4863名男性,2792名女性;平均年龄54.9±10.1岁)纳入本研究。比较了使用和未使用AI系统进行EGD检查时诊断出的上消化道肿瘤数量。

结果

分别对3841名和3814名受试者进行了使用和未使用AI系统的EGD检查。与未使用AI的EGD检查相比,使用AI应用的EGD检查活检操作更频繁,检查时间更长。使用和未使用AI的EGD检查诊断出的上消化道肿瘤分别为39例(1.02%)和24例(0.63%)(P = 0.062)。使用AI系统的EGD检查(30例,0.78%)和未使用AI系统的EGD检查(14例,0.37%)在食管和胃肿瘤检测率上存在显著差异(P = 0.017)。当根据内镜医师对EW10 - EG01应用的经验将其分为三组时,每组在使用AI进行EGD检查时食管和胃肿瘤的检测率均更高。

结论

由于食管和胃肿瘤检测率的提高,EW10 - EG01 AI系统的使用可能有助于EGD筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7e/11962169/b2d3b9574da9/cureus-0017-00000079935-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7e/11962169/513b6ea88843/cureus-0017-00000079935-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7e/11962169/b2d3b9574da9/cureus-0017-00000079935-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7e/11962169/513b6ea88843/cureus-0017-00000079935-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7e/11962169/b2d3b9574da9/cureus-0017-00000079935-i02.jpg

相似文献

1
Effectiveness of Artificial Intelligence in Screening Esophagogastroduodenoscopy.人工智能在食管胃十二指肠镜检查筛查中的有效性。
Cureus. 2025 Mar 2;17(3):e79935. doi: 10.7759/cureus.79935. eCollection 2025 Mar.
2
Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy.更长的观察时间增加了经食管胃十二指肠镜检查发现的肿瘤的比例。
Gastroenterology. 2017 Aug;153(2):460-469.e1. doi: 10.1053/j.gastro.2017.05.009. Epub 2017 May 10.
3
Combined gastric and colorectal cancer endoscopic screening may be cost-effective in Europe with the implementation of artificial intelligence: an economic evaluation.联合胃结直肠癌内镜筛查可能在欧洲具有成本效益,人工智能的实施:一项经济评估。
Eur J Gastroenterol Hepatol. 2024 Feb 1;36(2):155-161. doi: 10.1097/MEG.0000000000002680. Epub 2023 Nov 15.
4
Ability of artificial intelligence to detect T1 esophageal squamous cell carcinoma from endoscopic videos and the effects of real-time assistance.人工智能从内镜视频中检测 T1 食管鳞癌的能力及实时辅助的效果。
Sci Rep. 2021 Apr 8;11(1):7759. doi: 10.1038/s41598-021-87405-6.
5
Role of artificial intelligence-guided esophagogastroduodenoscopy in assessing the procedural completeness and quality.人工智能引导的食管胃十二指肠镜检查在评估操作完整性和质量方面的作用。
Indian J Gastroenterol. 2023 Feb;42(1):128-135. doi: 10.1007/s12664-022-01294-9. Epub 2023 Jan 30.
6
Artificial intelligence-assisted esophagogastroduodenoscopy improves procedure quality for endoscopists in early stages of training.人工智能辅助的食管胃十二指肠镜检查可提高处于培训初期的内镜医师的操作质量。
Endosc Int Open. 2025 Apr 15;13:a25476645. doi: 10.1055/a-2547-6645. eCollection 2025.
7
Artificial Intelligence as a Surrogate for Inspection Time to Assess Completeness in Esophagogastroduodenoscopy: A Prospective, Randomized, Noninferiority Study.使用人工智能替代检查时间评估食管胃十二指肠镜检查的完整性:一项前瞻性、随机、非劣效性研究
Clin Transl Gastroenterol. 2025 Mar 25;16(6):e00839. doi: 10.14309/ctg.0000000000000839. eCollection 2025 Jun 1.
8
Effect of anesthesia assistance on the detection rate of precancerous lesions and early esophageal squamous cell cancer in esophagogastroduodenoscopy screening: A retrospective study based on propensity score matching.麻醉辅助对食管胃十二指肠镜筛查中癌前病变及早期食管鳞状细胞癌检出率的影响:一项基于倾向评分匹配的回顾性研究
Front Med (Lausanne). 2023 Mar 23;10:1039979. doi: 10.3389/fmed.2023.1039979. eCollection 2023.
9
Current status of quality control in screening esophagogastroduodenoscopy and the emerging role of artificial intelligence.筛查性上消化道内镜检查中的质量控制现状及人工智能的新兴作用。
Dig Endosc. 2024 Jan;36(1):5-15. doi: 10.1111/den.14649. Epub 2023 Sep 8.
10
Capsule endoscopy is not as accurate as esophagogastroduodenoscopy in screening cirrhotic patients for varices.胶囊内镜在筛查肝硬化患者静脉曲张方面不如食管胃十二指肠镜准确。
Clin Gastroenterol Hepatol. 2012 Mar;10(3):254-8.e1. doi: 10.1016/j.cgh.2011.11.027. Epub 2011 Dec 8.

本文引用的文献

1
Prevalence of Gastric Epithelial Tumors in Helicobacter pylori-uninfected Individuals Undergoing a Medical Checkup.在接受体检的未感染幽门螺杆菌个体中胃上皮肿瘤的流行率。
Intern Med. 2024 Aug 15;63(16):2251-2258. doi: 10.2169/internalmedicine.2955-23. Epub 2024 Jan 13.
2
Prevalence of Raspberry-type Gastric Foveolar-type Tumor in Individuals Undergoing Medical Checkups.体检人群中覆盆子样胃小凹型肿瘤的流行情况。
Intern Med. 2023 Oct 1;62(19):2775-2781. doi: 10.2169/internalmedicine.1265-22. Epub 2023 Feb 22.
3
Application of Artificial Intelligence in Early Gastric Cancer Diagnosis.
人工智能在早期胃癌诊断中的应用。
Digestion. 2022;103(1):69-75. doi: 10.1159/000519601. Epub 2021 Oct 19.
4
Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type.胃底腺黏膜上皮肿瘤:与胃底腺型腺癌相关的新分类建议。
J Gastroenterol. 2021 Sep;56(9):814-828. doi: 10.1007/s00535-021-01813-z. Epub 2021 Jul 15.
5
Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer.人工智能驱动的胃癌内镜筛查和诊断的应用。
World J Gastroenterol. 2021 Jun 14;27(22):2979-2993. doi: 10.3748/wjg.v27.i22.2979.
6
Usefulness of the l-type Wako antibody J test.L型和光纯药抗体J试验的效用
JGH Open. 2021 May 7;5(6):673-678. doi: 10.1002/jgh3.12553. eCollection 2021 Jun.
7
Current status and future perspective of artificial intelligence applications in endoscopic diagnosis and management of gastric cancer.人工智能在胃癌内镜诊断和治疗中的应用现状及展望。
Dig Endosc. 2021 Jan;33(2):263-272. doi: 10.1111/den.13890. Epub 2020 Dec 27.
8
Artificial intelligence technique in detection of early esophageal cancer.人工智能技术在早期食管癌检测中的应用。
World J Gastroenterol. 2020 Oct 21;26(39):5959-5969. doi: 10.3748/wjg.v26.i39.5959.
9
Artificial intelligence in gastric cancer: Application and future perspectives.人工智能在胃癌中的应用及未来展望。
World J Gastroenterol. 2020 Sep 28;26(36):5408-5419. doi: 10.3748/wjg.v26.i36.5408.
10
Application of artificial intelligence using a convolutional neural network for diagnosis of early gastric cancer based on magnifying endoscopy with narrow-band imaging.应用卷积神经网络的人工智能技术在窄带成像放大内镜下对早期胃癌的诊断
J Gastroenterol Hepatol. 2021 Feb;36(2):482-489. doi: 10.1111/jgh.15190. Epub 2020 Jul 28.